Lyric Bio
PrivateLast Round
Seed
Dec 2, 2025
Total Funding Raised
$6.6M
Momentum Score
50 /100
Company Overview
Lyric Bio is a biotechnology company that is developing high-density tissue mimicking bioreactors to reduce Ig therapy dependence on human donation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, 3D Printing, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lyric Bio Comps
Public and private peers based on sector, stage, and business model.
Lyric Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 2, 2025 |
Lyric Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Draper Associates | Seed |
| Lucas Venture Group | Seed |
| Black Diamond Ventures | Seed |
| The Venture Collective | Seed |
| SOSV | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
Grew 71% QoQ from 7 to 12 employees.
- Jan 22, 2026
Grew 43% QoQ from 7 to 10 employees.
Lyric Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lyric Bio's valuation, stock price, and market status.
